Enliven Therapeutics, Inc. (ELVN)

$40.4 +9.19%

EARNINGS ANALYTICS

event_note Approx. Next Earnings: ~2026-08-13 APPROXIMATE

Across 21 earnings reports since May 07, 2020, Enliven Therapeutics, Inc. (ELVN) has a clear post-earnings pattern. It moves ±4.29% on average after reporting and finishes higher 57.1% of the time. Its largest post-earnings gain was +9.72% (Mar 15, 2022) and its largest decline was -19.01% (Mar 05, 2021). The next earnings report is predicted for 2026-08-13 (approximate).

Earnings Price Reaction

Scroll to zoom, drag to pan — click earnings dots for details

Beat Miss

Earnings Impact

Total Earnings

Avg Abs. Movement

±4.29%

Positive %

57.1%

Negative %

42.9%

Historical Earnings Statistics

Date	Timing	Open	High	Close	Volume	Movement %	SEC Filing
May 07, 2026	☽ POST	$40.55	$41.00	$40.21	21,404	+1.19%	open_in_new
Mar 03, 2026	☽ POST	$28.67	$29.45	$28.75	657,800	+4.28%	open_in_new
Nov 12, 2025	☽ POST	$20.00	$20.62	$20.30	424,900	-0.15%	open_in_new
Aug 13, 2025	☽ POST	$19.05	$20.11	$19.98	361,200	-1.08%	open_in_new
May 14, 2025	☽ POST	$19.98	$20.96	$19.89	400,400	-10.41%	open_in_new
Mar 13, 2025	☽ POST	$21.12	$21.12	$20.29	141,700	+2.22%	open_in_new
Nov 13, 2024	☽ POST	$27.59	$27.59	$25.80	279,900	-3.41%	open_in_new
Aug 13, 2024	☽ POST	$21.55	$22.12	$21.52	81,000	+1.3%	open_in_new
May 14, 2024	☽ POST	$24.83	$25.00	$23.87	342,700	+0.54%	open_in_new
Mar 14, 2024	☽ POST	$12.07	$13.11	$11.54	99,700	+3.73%	open_in_new
Nov 09, 2023	☽ POST	$12.50	$13.26	$11.55	40,900	-1.47%	open_in_new
Aug 10, 2023	☽ POST	$18.04	$18.04	$17.52	55,100	+0.11%	open_in_new
May 11, 2023	☽ POST	$20.03	$20.03	$19.10	51,100	+1.57%	open_in_new
Mar 15, 2022	☀ PRE	$7.40	$7.40	$6.32	33,050	+9.72%	open_in_new
Nov 09, 2021	☀ PRE	$14.88	$16.20	$15.64	27,350	+5.39%	open_in_new
Aug 06, 2021	☀ PRE	$23.40	$23.52	$23.16	53,050	-1.53%	open_in_new
May 11, 2021	☀ PRE	$27.32	$30.60	$29.84	31,925	+7.34%	open_in_new
Mar 05, 2021	☀ PRE	$40.44	$43.00	$39.88	139,400	-19.01%	open_in_new
Nov 05, 2020	☀ PRE	$66.16	$73.08	$65.20	4,150	-2.1%	open_in_new
Aug 14, 2020	☀ PRE	$83.96	$85.04	$82.44	5,100	+1.98%	open_in_new
May 07, 2020	☀ PRE	$87.88	$94.80	$80.00	18,225	-11.5%	open_in_new

event

Earnings Count

Total earnings in dataset

trending_up

Avg Abs. Movement

±4.29%

Avg % price change on earnings

description

SEC Filings

View

Browse all SEC filings

SEC Filing Types

description SCHEDULE 13G/A

13 chevron_right

Recent SEC Filings

10 most recent

Form	Date Filed	View on EDGAR
8-K	20260610	open_in_new SEC.gov
4	20260609	open_in_new SEC.gov
144	20260605	open_in_new SEC.gov
4	20260520	open_in_new SEC.gov
144	20260518	open_in_new SEC.gov
SCHEDULE 13G/A	20260515	open_in_new SEC.gov
SCHEDULE 13G/A	20260515	open_in_new SEC.gov
SCHEDULE 13G/A	20260515	open_in_new SEC.gov
SCHEDULE 13G/A	20260515	open_in_new SEC.gov
SCHEDULE 13G/A	20260515	open_in_new SEC.gov

Frequently asked about ELVN earnings

When does Enliven Therapeutics, Inc. report earnings next? expand_more

Enliven Therapeutics, Inc. (ELVN)'s next earnings date is approximate for 2026-08-13. This is a prediction based on its historical quarterly reporting pattern, not a company-confirmed date.

How much does ELVN stock move after earnings? expand_more

Over 21 reports, ELVN has moved an average of ±4.29% the session after earnings, closing higher 57.1% of the time.

What was ELVN's biggest post-earnings move? expand_more

ELVN's largest post-earnings gain on record was +9.72% on Mar 15, 2022, and its largest decline was -19.01% on Mar 05, 2021.

Where can I find Enliven Therapeutics, Inc.'s SEC filings? expand_more

All of Enliven Therapeutics, Inc.'s SEC filings — 10-K, 10-Q, 8-K and more — are listed in the SEC filings section on this page, each linking to the original document on SEC.gov.